Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain
· Delayed Price · Currency is EUR 53.95
-0.05 (-0.09%)
May 13, 2025, 1:38 PM CET
BME:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 154.89M EUR in the quarter ending March 31, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 767.47M, down -1.49% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
767.47M
Revenue Growth
-1.49%
P/S Ratio
3.60
Revenue / Employee
349.32K
Employees
2,197
Market Cap
2.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.21B |
| Almirall | 990.63M |
| Faes Farma | 524.02M |
| Pharma Mar | 175.75M |
| Clínica Baviera | 265.72M |
| Laboratorio Reig Jofre | 338.90M |
| Atrys Health | 218.10M |
| Oryzon Genomics | 7.36M |
Laboratorios Farmaceuticos Rovi News
- 2 months ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus
- 2 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call Transcript - Seeking Alpha